Tredje AP fonden grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 17.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 381,905 shares of the healthcare conglomerate’s stock after buying an additional 55,500 shares during the quarter. UnitedHealth Group accounts for 1.9% of Tredje AP fonden’s portfolio, making the stock its 8th largest position. Tredje AP fonden’s holdings in UnitedHealth Group were worth $194,489,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Swedbank AB acquired a new position in shares of UnitedHealth Group during the first quarter worth about $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in UnitedHealth Group by 107.8% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after acquiring an additional 1,196,758 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after purchasing an additional 880,183 shares in the last quarter. Baillie Gifford & Co. grew its holdings in UnitedHealth Group by 1,125.4% during the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock valued at $455,281,000 after purchasing an additional 821,050 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado lifted its holdings in UnitedHealth Group by 3,464.9% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 825,311 shares of the healthcare conglomerate’s stock worth $434,501,000 after buying an additional 802,160 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.
Analyst Upgrades and Downgrades
UNH has been the topic of several recent analyst reports. UBS Group boosted their price target on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research note on Thursday, July 18th. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and increased their target price for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. JPMorgan Chase & Co. increased their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research note on Monday. Finally, Robert W. Baird boosted their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, UnitedHealth Group has an average rating of “Buy” and a consensus price target of $614.17.
Insider Activity at UnitedHealth Group
In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.
UnitedHealth Group Stock Performance
UNH opened at $577.89 on Wednesday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94. The stock has a market cap of $531.88 billion, a PE ratio of 35.32, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The business’s 50 day moving average is $572.79 and its 200-day moving average is $519.00. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same period last year, the company earned $6.14 earnings per share. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. On average, analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.45%. The ex-dividend date of this dividend is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- 3 Stocks to Consider Buying in October
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- High Flyers: 3 Natural Gas Stocks for March 2022
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.